1sbg: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Eric Martz (talk | contribs) added caution about possible fraud |
||
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
{{Template:Possible_fraud}} | |||
[[Image:1sbg.png|left|200px]] | [[Image:1sbg.png|left|200px]] | ||
Revision as of 04:12, 5 January 2010
|
CAUTION: This structure might be fraudulent. See the official statement of the University of Alabama recommending retraction, and the wwPDB statement on Retraction of UAB PDB entries. Although not listed in the above statements, the reliability of 1bgx, 1ay1, 1hef, 1heg, 1sbg, 1hps, and 1hos have been called into question since they were co-authored by H. M. Krishna Murthy: see discussion of fraud. See also the list of recommended retractions. |
AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSISAN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS
Template:ABSTRACT PUBMED 7918383
About this StructureAbout this Structure
1SBG is a 2 chains structure of sequences from Human immunodeficiency virus type 1 (isolate bh10). Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Abdel-Meguid SS, Metcalf BW, Carr TJ, Demarsh P, DesJarlais RL, Fisher S, Green DW, Ivanoff L, Lambert DM, Murthy KH, et al.. An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement: crystallographic and pharmacokinetic analysis. Biochemistry. 1994 Oct 4;33(39):11671-7. PMID:7918383
Page seeded by OCA on Wed Feb 18 09:30:18 2009